Research brings hope, advancing Glioblastoma treatments – Mayo Clinic
Mayo Clinic’s shared a post on LinkedIn:
“Globally, approximately 300,000 people are diagnosed each year with glioblastoma, an aggressive type of brain cancer.
‘Research is crucial to find hope and healing on every corner of our operating room, in every corner of our laboratory, and to connect those two, ultimately, through our patients,’ says Alfredo Quinones-Hinojosa, a neurosurgeon at Mayo Clinic.
Learn more about how research is making strides, giving patients more options and hope.”
Nika Kovach, Medical Assistant at Sun Valley Arthritis, reshared the post by Mayo Clinic on LinkedIn, adding:
“Glioblastoma – highly malignant brain tumor. Can cross corpus callosum ‘butterfly glioma’. Associated with Epidermal Growth Factor Receptor (EGFR) amplification.
Astrocyte origin. Astrocytes are Central Nervous System glial cells. Physical support, repair and removal of excess neurotransmitters, component of Blood Brain Barrier (BBB), glycogen fuel reserve buffer, GFAP+.”
Additional information
Source: Mayo Clinic/LinkedIn and Nika Kovach/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023